Cargando…
Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System †
More than 50 years after the first description of Bronchopulmonary dysplasia (BPD) by Northway, this chronic lung disease affecting many preterm infants is still poorly understood. Additonally, approximately 40% of preterm infants suffering from severe BPD also suffer from Bronchopulmonary dysplasia...
Autores principales: | Chao, Cho-Ming, Chong, Lei, Chu, Xuran, Shrestha, Amit, Behnke, Judith, Ehrhardt, Harald, Zhang, Jinsan, Chen, Chengshui, Bellusci, Saverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464452/ https://www.ncbi.nlm.nih.gov/pubmed/32796770 http://dx.doi.org/10.3390/cells9081875 |
Ejemplares similares
-
Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice
por: Das, Pragnya, et al.
Publicado: (2021) -
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
por: Shahzad, Tayyab, et al.
Publicado: (2016) -
Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
por: Chen, Xin, et al.
Publicado: (2019) -
Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022) -
Systemic Steroids in Preventing Bronchopulmonary Dysplasia (BPD): Neurodevelopmental Outcome According to the Risk of BPD in the EPICE Cohort
por: Zayat, Noura, et al.
Publicado: (2022)